Bhubaneswar: Indigenously developed Covaxin COVID-19 vaccine by Bharat Biotech is likely to be priced lower than Serum Institute’s Covishield.
Covishield will be sold at Rs 200 per vial to the government and at Rs 1,000 in the private market.
The Hyderabad-based company is finalising the prices with the government, the Business Standard reported. Covaxin is currently in 3rd phase trials but has been approved for emergency use along with Serum’s Covishield developed by Oxford-AstraZeneca.
Union Minister Harsh Vardhan on Thursday said both the vaccines are “on the verge of being available in the country”. The government is focusing on ensuring seamless last-mile delivery of the vaccine, he added.
With dry runs complete in most places, the vaccines are likely to be transported in a day or two.
For vaccine transportation, private airlines will also be used. Pune will be the central hub and the vaccines will be sent to around 41 destinations from there. New Delhi and Karnal will be mini hubs for north India while Kolkata and Chennai will be hubs for eastern and southern parts respectively.
Also Read: COVID-19 Spike: Govt Urges States To Stay Strict & Vigil
Bhubaneswar: Odisha unit of BJP on Sunday alleged that the chief minister's office (CMO) was…
Bhubaneswar: The Bhubaneswar Film Festival (BFF) will be organising a three-day exclusive festival of Odia…
Ahmedabad: Virat Kohli has been scoring loads of runs in IPL 2024, having crossed 500…
Bhubaneswar: Odisha's identity and language under threat under the rule of BJD government and the…
Bhubaneswar: Commissionerate Police busted a cyber crime gang and arrested three persons involved in an…
Bengaluru: As if an alleged sex scandal and SIT probe wasn’t enough, Janata Dal (Secular)…
Bhubaneswar: BJP's national president JP Nadda on Sunday intensified the party's poll pitch in Odisha…
New Delhi: Eight days after postponing his two-day trip to India, Elon Musk arrived in Beijing…